Assessment of tobacco heating product THP1.0. Part 5: In vitro dosimetric and cytotoxic assessment

Regulatory Toxicology and Pharmacology

Volumn 93, Issue , 2018, Pages 52-61

  Jaunky, Tomasz ^a   Adamson, Jason ^a   Santopietro, Simone ^a   Terry, Anya ^a   Thorne, David ^a   Breheny, Damien ^a   Proctor, Christopher ^a   Gaça, Marianna ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

Author keywords

Dosimetry; In vitro cytotoxicity; Neutral Red Uptake; Nicotine; RM20S; Tobacco heating products

Indexed keywords

NICOTINE; TOBACCO SMOKE; CYTOTOXIN;

ACCURACY; AEROSOL; ARTICLE; CELL VIABILITY; CIGARETTE; CONTROLLED STUDY; CYTOTOXICITY TEST; DILUTION; DOSIMETRY; EXPOSURE; HEATING; HUMAN; HUMAN CELL; IN VITRO STUDY; NCI-H292 CELL LINE; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; TOBACCO; ANALYSIS; CELL LINE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; ELECTRONIC CIGARETTE; PHYSIOLOGY; PROCEDURES; RESPIRATORY MUCOSA;

CELL LINE; CELL SURVIVAL; CYTOTOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRONIC NICOTINE DELIVERY SYSTEMS; HEATING; HUMANS; NICOTINE; RESPIRATORY MUCOSA; TOBACCO PRODUCTS;

EID: 85033444816     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2017.09.016     Document Type: Article

References (48)

1. Adamson, J., Li, X., Cui, H., Thorne, D., Xie, F., Gaca, M.D., Nicotine quantification in vitro: a consistent dosimetry marker for e-cigarette aerosol and cigarette smoke generation. Appl. In Vitro Toxicol. 3:1 (2017), 14–27.
2. Adamson, J., Thorne, D., Zainuddin, B., Baxter, A., McAughey, J., Gaca, M., Application of dosimetry tools for the assessment of e-cigarette aerosol and cigarette smoke generated on two different in vitro exposure systems. Chem. Cent. J., 10, 2016, 74.
3. Adamson, J., Azzopardi, D., Errington, G., Dickens, C., McAughey, J., Gaҫa, M.D., Assessment of an in vitro whole cigarette smoke exposure system: the Borgwaldt RM20S 8-syringe smoking machine. Chem. Cent. J., 5, 2011, 50.
4. Azzopardi, D., Haswell, L.E., Foss-Smith, G., Hewitt, K., Asquith, N., Corke, S., Phillips, G., Evaluation of an air liquid interface cell culture model for studies on the inflammatory and cytotoxic responses to tobacco smoke aerosols. Toxicol. In Vitro 29 (2015), 1720–1728.
5. Azzopardi, D., Patel, K., Jaunky, T., Santopietro, S., Camacho, O.M., McAughey, J., Gaca, M., Electronic cigarette aerosol induces significantly less cytotoxicity than tobacco smoke. Toxicol. Mechan. Methods 26:6 (2016), 477–491.
6. Banerjee, A., Haswell, L.E., Baxter, A., Parmar, A., Azzopardi, D., Corke, S., Thorne, D., Adamson, J., Mushonganono, J., Gaca, M., Minet, E., Differential gene expression using RNA sequencing profiling in a reconstituted airway epithelium exposed to conventional cigarette smoke or electronic cigarette aerosols. Appl. In Vitro Toxicol. 3:1 (2017), 84–98.
7. Breheny, D., Adamson, J., Azzopardi, D., Baxter, A., Bishop, E., Carr, T., Crooks, I., Hewitt, K., Jaunky, T., Larard, S., Lowe, F., Oke, O., Taylor, M., Santopietro, S., Thorne, D., Zainuddin, B., Gaca, M., Liu, C., Murphy, J., Proctor, C., A novel hybrid tobacco product that delivers a tobacco flavour note with vapour aerosol (Part 2): In vitro biological assessment and comparison with different tobacco-heating products. Food Chem. Toxicol. 106:Pt A (2017 Aug), 533–546, 10.1016/j.fct.2017.05.023 Epub 2017 Jun 5.
8. Cancer Research UK, Our policy on e-cigarettes. http://www.cancerresearchuk.org/about-us/we-develop-policy/our-policy-on-preventing-cancer/our-policy-on-tobacco-control-and-cancer/our-policy-on-e-cigarettes, 2017 (Accessed 12 April 2017).
9. Doolittle, D., Lee, C., Ivett, J., Mirsalis, J., Riccio, E., Rudd, C., Burger, G., Hayes, A., Comparative studies on the genotoxic activity of mainstream smoke condensate from cigarettes which burn or only heat tobacco. Environ. Mol. Mutagen 15 (1990), 93–105.
10. Eaton, D., Jakaj, B., Forster, M., Nicol, J., Liu, C., McAdam, K., Murphy, M., Trani, M., Proctor, C., Assessment of tobacco heating product THP1.0. Part 2: product design, operation and thermophysical characterisation. Regul. Toxicol. Pharmacol., 2017 (this issue).
11. Eldridge, A., Betson, T.R., Vinicius Gama, M., et al. Variation in tobacco and mainstream smoke toxicant yields from selected commercial cigarette products. Regul. Toxicol. Pharmacol. 71 (2015), 409–427.
12. Fields, W., Maione, A., Keyser, B., Bombick, B., Characterization and application of the VITROCELL VC1 Smoke Exposure System and 3D EpiAirway models for toxicological and e-cigarette evaluations. Appl. In Vitro Toxicol. 3:1 (2017), 68–83.
13. Forster, M., Fiebelkorn, S., Yurteri, C., Mariner, D., Liu, C., Wright, C., McAdam, K., Murphy, J., Proctor, C., Assessment of tobacco heating product THP1.0. Part 3: comprehensive chemical characterisation —harmful and potentially harmful aerosol emissions. Regul. Toxicol. Pharmacol., 2017 (this issue).
14. Foy, D., Bombick, B., Bombick, D., Doolittle, D., Mosberg, A., Swauger, J., A comparison of in vitro toxicities of cigarette smoke condensate from Eclipse cigarettes and four commercially available ultra-low-“tar” cigarettes. Food Chem. Toxicol. 42 (2004), 237–243.
15. Goniewicz, M., Knysak, J., Gawron, M., Kosmider, L., Sobczak, A., Kurek, J., Prokopowicz, A., Jablonska-Czapla, M., Rosik-Dulewska, C., Havel, C., Jacob, P. 3rd, Benowitz, N., Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob. Control 23 (2014), 133–139.
16. Gonzalez-Suarez, I., Martin, F., Marescotti, D., Guedj, E., Acali, S., Johne, S., Dulize, R., Baumer, K., Peric, D., Goedertier, D., Frentzel, S., Ivanov, N.V., Mathis, C., Hoeng, J., Peitsch, M.C., In vitro systems toxicology assessment of a candidate modified risk tobacco product shows reduced toxicity compared to that of a conventional cigarette. Chem. Res. Toxicol. 29:1 (2016), 3–18.
17. Ishikawa, S., Ito, S., Repeated whole cigarette smoke exposure alters cell differentiation and augments secretion of inflammatory mediators in air liquid interface three dimensional co-culture model of human bronchial tissue. Toxicol. In Vitro 38 (2017), 170–178.
18. Ishikawa, S., Suzuki, T., Nagata, Y., Analysis of cigarette smoke deposition within an in vitro exposure system for simulating exposure in the human respiratory tract. Beitr. zur Tab. Int. 27:1 (2016), 20–29.
19. Iskandar, A.R., Mathis, C., Martin, F., Leroy, P., Sewer, A., Majeed, S., Kuehn, D., Trivedi, K., Grandolfo, D., Cabanski, M., Guedj, E., Merg, C., Frentzel, S., Ivanov, N.V., Peitsch, M.C., Hoeng, J., 3D nasal cultures: systems toxicological assessment of a candidate modified risk tobacco product. ALTEX 34:1 (2017), 23–48.
20. Kaur, N., Lacasse, M., Roy, J.-P., Cabral, J.-L., Adamson, J., Errington, G., Waldron, K.C., Gaҫa, M.D., Morin, A., Evaluation of precision and accuracy of the Borgwaldt RM20S smoking machine designed for in vitro exposure. Inhal. Toxicol. 22:14 (2010), 1174–1183.
21. Kuehn, D., Majeed, S., Guedj, E., Dulize, R., Baumer, K., Iskandar, A., Boue, S., Martin, F., Kostadinova, R., Mathis, C., Ivanov, N.V., Frentzel, S., Hoeng, J., Peitsch, M.C., Impact assessment of repeated exposure of organotypic 3D bronchial and nasal tissue culture models to whole cigarette smoke. J. Vis. Exp., 96, 2015, e52325.
22. Li, X., In vitro toxicity testing of cigarette smoke based on the air liquid interface exposure: a review. Toxicol. In Vitro 36 (2016), 105–113.
23. Lowe, F., Fearon, I.M., Camacho, O.M., Minet, E., Murphy, J., A framework for the biological assessment of reduced risk tobacco and nicotine products. Recent Adv. Tob. Sci. 41 (2015), 51–81.
24. Majeed, S., Frentzel, S., Wagner, S., Kuehnn, D., Leroy, P., Guy, P.A., Knorr, A., Hoeng, J., Peitsch, M.C., Characterization of the Vitrocell 24/48 in vitro aerosol exposure system using mainstream cigarette smoke. Chem. Cent. J., 8, 2014, 62.
25. Margham, J., McAdam, K., Forster, M., Liu, C., Wright, C., Mariner, D., Proctor, C., Chemical composition of an e-cigarette aerosol – a quantitative comparison with cigarette smoke. Chem. Res. Toxicol. 29:10 (2016), 1662–1678.
26. Maunders, H., Patwardhan, S., Phillips, J., Clack, A., Richter, A., Human bronchial epithelial cell transcriptome: gene expression changes following acute exposure to whole tobacco smoke in vitro. Am. J. Physiol. 292 (2007), L1248–L1256.
27. McNeill, A., Brose, L.S., Calder, R., Hitchman, S.C., Hajek, P., McRobbie, H., E-cigarettes: an Evidence Update., 2015 A report commissioned by Public Health England https://www.gov.uk/government/publications/e-cigarettes-an-evidence-update (Accessed 12 April 2017).
28. Misra, M., Leverette, R.D., Cooper, B.T., Bennett, M.B., Brown, S.E., Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols. Int. J. Environ. Res. Public Health 2014:11 (2014), 11325–11347.
29. Mülhopt, S., Diabate, S., Krebs, T., Weiss, C., Paur, H.R., Lung toxicity determination by in vitro exposure at the air liquid interface with an integrated online dose measurement. J. Phys. Conf. Ser., 170(1), 2009 012008.
30. Munakata, S., Ishimori, K., Takanami, Y., Ishikawa, S., Ito, S., Comparative Effects of Cigarette Smoke and Novel Tobacco Vapour on in Vitro Cellular Responses in Human Bronchial Epithelial Cells. 2017, Society of Toxicology 2017, Baltimore, MD Poster number P539.
31. Murphy, J., Gaca, M., Lowe, F., Minet, E., Breheny, D., Gee, K., Camacho, O., Fearon, I.M., Liu, C., Wright, C., McAdam, K., Proctor, C., A modified risk tobacco and nicotine product assessment framework and the demonstration of a closed modular electronic cigarette as a potentially reduced risk product. Regul. Toxicol. Pharmacol., 2017 (submitted).
32. National Institutes of Health (NIH), Guidance Document on Using in Vitro Data to Estimate in Vivo Starting Doses for Acute Toxicity. Publication 01–4500, 2001, National Institute of Environmental Health Sciences, Washington, DC https://ntp.niehs.nih.gov/pubhealth/evalatm/test-method-evaluations/acute-systemic-tox/in-vitro/guidance-document/index.html (Accessed 12 April 2017).
33. Nutt, D.J., Phillips, L.D., Balfour, D., Curran, H.V., Dockrell, M., Foulds, J., Fagerstrom, K., Letlape, K., Milton, A., Polosa, R., Ramsey, J., Sweanor, D., Estimating the harms of nicotine containing products using the MCDA approach. Eur. Addict. Res. 20:5 (2014), 218–225.
34. Phillips, J., Kluss, B., Richter, A., Massey, E., Exposure of bronchial epithelial cells to whole tobacco smoke: assessment of cellular responses. Altern. Lab. Anim. 33 (2005), 239–248.
35. Poynton, S., Sutton, J., Goodall, S., Margham, J., Forster, M., Scott, J.K., Liu, C., McAdam, Murphy J., Proctor, C., A novel hybrid product that heats tobacco through controlled aerosol release (Part 1): product operation and preliminary aerosol chemistry assessment. Food Chem. Toxicol. 106 (2017), 522–532.
36. Schaller, J.P., Keller, D., Poget, L., Pratte, P., Kaelin, E., McHugh, D., Cudazzo, G., Smart, D., Tricker, A.R., Gautier, L., Yerly, M., Pires, R.R., Le Bouhellec, S., Ghosh, D., Hofer, I., Garcia, E., Vanscheeuwijck, P., Maeder, S., Evaluation of the Tobacco Heating System 2.2. Part 2: chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. Regul. Toxicol. Pharmacol. 81 (2016), S27–S47.
37. Scian, M.J., Oldham, M.J., Kane, D.B., Edmiston, J.S., McKinney, W.J., Characterization of a whole smoke in vitro exposure system (Burghart Mimic Smoker-01). Inhal. Toxicol. 21 (2009), 234–243.
38. Scott, K., Saul, J., Crooks, I., Camacho, O.M., Dillon, D., Meredith, C., The resolving power of in vitro genotoxicity assays for cigarette smoke particulate matter. Toxicol. In Vitro 27 (2013), 1312–1319.
39. Shahab, L., Goniewicz, M.L., Blount, B.C., Brown, J., McNeill, A., Alwis, K.U., Feng, J., Wang, L., West, R., Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional study. Ann. Intern. Med. 166:6 (2017), 390–400.
40. Smith, M.R., Clark, B., Luedicke, F., Schaller, J.P., Vanscheeuwijck, P., Hoeng, J., Peitsch, M.C., Evaluation of the tobacco heating system 2.2. Part 1: description of the system and the scientific assessment program. Regul. Toxicol. Pharmacol. 81 (2016), S17–S26.
41. Steiner, S., Majeed, S., Kratzer, G., Hoeng, J., Frentzel, S., A new fluorescence-based method for characterizing in vitro aerosol exposure systems. Toxicol. In Vitro 38 (2016), 150–158.
42. Supplier Quality Requirements Taskforce, Daimler Chrysler Corporation, Ford Motor Company, General Motors Corporation, Measurement Systems Analysis, Reference Manual. third ed., 2002, General Motors, Michigan, USA.
43. Taylor, M., Carr, T., Oke, O., Jaunky, T., Breheny, D., Lowe, F., E-cigarette aerosols induce lower oxidative stress in vitro when compared to tobacco smoke. Toxicol. Mech. Methods 26 (2016), 465–476.
44. Thorne, D., Adamson, J., A review of in vitro cigarette smoke exposure systems. Exp. Toxicol. Pathol. 65 (2013), 1183–1193.
45. Thorne, D., Larard, S., Baxter, A., Meredith, C., Gaca, M., The comparative in vitro assessment of e-cigarette and cigarette smoke aerosols using the yH2AX assay and applied dose measurements. Toxicol. Lett. 265 (2017), 170–178.
46. Thorne, D., Crooks, I., Hollings, M., Seymour, A., Meredith, C., Gaca, M., The mutagenic assessment of an electronic-cigarette and cigarette smoke using the Ames assay in strains TA98 and TA100. Mutat. Res. 812 (2016), 29–38.
47. Thorne, D., Kilford, J., Hollings, M., Dalrymple, A., Ballantyne, M., Meredith, C., Dillon, D., The mutagenic assessment of mainstream cigarette smoke using the Ames assay: a multi-strain approach. Mutat. Res. 782 (2015), 9–17.
48. US Department of Health and Human Services, The Health Consequences of Smoking 50 Years of Progress: a Report of the Surgeon General, 2014., 2014 Atlanta, USA http://www.surgeongeneral.gov/library/reports/50-years-of-progress/index.html (Accessed 24 October 2016).